CLINICAL_TRIALS
trial_result
· 2016-12-08
Clinical Trial Update: Phase II Sunitinib Prog Met AIPC [Phase 2]
Summary
Phase II trial of sunitinib in metastatic prostate cancer completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: US Oncology Research | Conditions: Metastatic Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-12-08